Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study
Titel:
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study
Auteur:
Jankowitz, Rachel C. Abraham, Jame Tan, Antoinette R. Limentani, Steven A. Tierno, Marni B. Adamson, Laura M. Buyse, Marc Wolmark, Norman Jacobs, Samuel A.